Provided by Tiger Trade Technology Pte. Ltd.

JACOBIO-B

6.250
+0.2504.17%
Volume:4.22M
Turnover:26.17M
Market Cap:4.89B
PE:-28.42
High:6.325
Open:6.000
Low:6.000
Close:6.000
52wk High:11.800
52wk Low:3.980
Shares:782.00M
HK Float Shares:782.00M
Volume Ratio:1.52
T/O Rate:0.54%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.220
ROE:46.30%
ROA:19.43%
PB:3.10
PE(LYR):-28.42
PS:5.67

Loading ...

Jacobio Pharma Projects First‐Ever Profit, Expects ≥RMB600.00 million Net Income for 1H 2026 on Licensing Windfall

Bulletin Express
·
Aug 10

Biotech Firm JACOBIO-B Anticipates First-Ever Profit of at Least RMB 600 Million

Stock News
·
Aug 10

Jacobio Pharmaceuticals Sees Significant Growth in Hy Revenue

THOMSON REUTERS
·
Aug 10

Jacobio Pharmaceuticals - Expects Net Profit of not Less than Rmb600 Mln for Six Months Ended June 30, 2026

THOMSON REUTERS
·
Aug 10

Jacobio Pharmaceuticals Forecasts H1 Net Profit at Least RMB 600 Million

Reuters
·
Aug 10

Jacobio Doses First Patient in Phase Iia China Trial of Jab-8263 for Rheumatoid Arthritis

Reuters
·
Jul 27

Jacobio Pharmaceuticals executes HKD 0.50 million on-market buyback, lifting treasury stock to 9.58 million shares

Bulletin Express
·
Jul 24

Jacobio Pharmaceuticals executes HK$0.50 million share buyback, lifts treasury stock to 9.48 million shares

Bulletin Express
·
Jul 23

JACOBIO-B Spends HK$497,000 on Share Buyback on July 23rd

Stock News
·
Jul 23

Jacobio Pharma Files HKEX Next-day Disclosure Return on Share Repurchase at HKD 5.08 Each

Reuters
·
Jul 23

JACOBIO-B repurchases 98,400 shares; treasury stock reaches 9.38 million

Bulletin Express
·
Jul 21

JACOBIO-B Allocates HK$498,600 for Share Buyback on July 21

Stock News
·
Jul 21

Jacobio Pharmaceuticals Files HKEX Next-day Return Disclosing Share Repurchase at HKD 5.07 Each

Reuters
·
Jul 21

JACOBIO-B Announces First Patient Dosed in China for Pivotal KRAS Inhibitor Combination Trial

Stock News
·
Jul 20

Jacobio initiates first China dosing in Phase Ib/III study of pan-KRAS inhibitor JAB-23E73 for first-line KRAS-mutant pancreatic cancer

Bulletin Express
·
Jul 20

Jacobio Doses First Patient in China Phase Ib/iii Trial of Pan-kras Inhibitor Jab-23e73 in Kras-mutant Pancreatic Cancer

Reuters
·
Jul 20

Jacobio-B completes HKD0.49 million on-market buyback; treasury shares rise to 9.28 million

Bulletin Express
·
Jul 17

JACOBIO-B Executes Share Buyback, Spending HK$488k on July 17th

Stock News
·
Jul 17

Jacobio Pharmaceuticals Files HKEX Next-day Return Disclosing Share Buyback at HKD 4.64-4.66

Reuters
·
Jul 17

Jacobio Pharmaceuticals Executes HKD 0.50 Million Share Buy-Back, Lifts Treasury Stock to 9.18 Million Shares

Bulletin Express
·
Jul 14